Delivery Order SPE2D021DA002-SPE2D325F342K
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order on July 30, 2025, for 60 tablets of Isentress 400 mg with a ceiling value of $6,280.86. This firm fixed-price delivery order, which is due for completion by July 31, 2025, was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The contract represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,280.86 on August 18, 2025, for the supply of Isentress 400 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The award represents a continuation of DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 25, 2025, to supply Isentress 400 mg tablets (60-count units) to the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, valued at $20,936.20, represents a single-award contract with an ultimate completion date of August 26, 2025. The award was made without a set-aside designation, enabling DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,381.17, is for the delivery of Isentress 400 mg tablets. This order is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued up to $4,999,999 through 2025. Through this IDV, DMS Pharmaceutical provides a wide...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Isentress 400 mg tablet. The order has a potential value of $1,336.79 and a completion date of April 4, 2023. DMS Pharmaceutical Group holds multiple federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals and medical products in support of military treatment facilities...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Isentress 400 mg Tablet. The potential value of this order is $2,541.64 and the period of performance runs through February 23, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals...
- This federal contract award, valued at $13,811.70, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Isentress 400 mg tablets, with a completion date of June 25, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $9,238.18 and covers the delivery of the pharmaceutical product Isentress 400 mg tablets. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Isentress 400 mg tablet. The potential value of this delivery order is $1,336.79 and the period of performance ends on September 19, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $16,574.04 firm-fixed-price contract is for the delivery of Isentress 400 mg tablets, a prescription pharmaceutical product. The contract has a completion date of January 29, 2024. DMS Pharmaceutical Group Inc. holds an indefinite delivery contract, SPE2DB, with the DLA valued up to $4,999,999...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F342KDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18.8K on August 25, 2025, for the supply of Isentress 400 mg tablets (60-count units). The award was issued by the Defense Logistics Agency's Medical Supply Chain division with an ultimate completion date of August 26, 2025. This delivery order carries no set-aside designation and represents a single purchase order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500M through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities nationwide. Isentress (raltegravir) is an integrase strand transfer inhibitor used in antiretroviral therapy for HIV treatment. This delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, leveraging its SPE2DB contract vehicle to provide both branded prescription medications and specialty pharmaceuticals to Department of Defense healthcare sites. The vendor's consistent performance on similar delivery orders covering oncology treatments, vaccines, biologics, and other essential medications demonstrates its capability to meet the specialized procurement requirements of military medical facilities across the United States.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.8k | 8/25/25 |